Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Generation Bio

generationbio.com

Latest From Generation Bio

Oxurion Eyes $12bn Opportunity After Restructuring

The Belgium-headquartered group is pulling the plug on its dry AMD research efforts and investments in cancer venture Oncurious to focus on two early-stage compounds that show promise for diabetic macular edema and other retinal diseases.

Ophthalmic Business Strategies

Riding On Exosome Potential, Evox Eyes Unicorn Status

A financing round that was significantly oversubscribed by new and existing investors will help advance the Oxford-headquartered biotech's exosome therapeutics into the clinic and expand its technology platform.

Financing Strategy

Finance Watch: Four Offerings In One Week As Biopharma Keeps Its IPO Market Lead

Lantern, Avidity, Generation Bio and Vaxcyte launched initial public offerings during the second week of June as biopharma continues to intrigue IPO investors. Also, Blackstone invested $350m in Reata's bardoxolone and Checkmate’s $85m series C led recent VC deals. 

Financing Business Strategies

Finance Watch: Investors Bet Billions On Big Biopharma Offerings

Public Company Edition: After an initial hit to valuations from COVID-19, massive amounts of money have been raised by drug developers, such as argenx with a $862.5m stock sale. However, only two IPOs launched in the US in May, including ADC with a $267m offering.

Financing Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
  • Diversified
  • Pharmaceuticals
  • Pharmaceuticals
    • Chiral Chemistry
    • Drug Delivery
  • Biotechnology
    • Antisense, Oligonucleotides
    • Gene Therapy, Cell Therapy
    • Large Molecule
    • Liposomes
    • Nanotechnology, Chips, etc.
    • Pharmacogenetics-Pharmacogenomics
    • Synthesis Technologies, Production Processes
    • Transgenics
    • Large Molecule
      • Antibodies
    • Drug Discovery Tools
      • Bioinformatics
      • Molecular Diversity
UsernamePublicRestriction

Register